Merck和Siemens扩大AI伙伴关系,利用先进的软件和数据工具加速药物开发。 Merck and Siemens expand AI partnership to speed drug development using advanced software and data tools.

Merck和Siemens扩大了伙伴关系,利用AI加速药物发现和开发,整合软件、自动化和数据分析,以简化药物生命周期。 Merck and Siemens have expanded their partnership to accelerate drug discovery and development using AI, integrating software, automation, and data analytics to streamline the pharmaceutical lifecycle. 合作利用Siemens的Luma平台(该平台是通过购买Dotmatics获得的),加强科学工作流程,改善研究与生产之间的数据共享。 The collaboration leverages Siemens’ Luma platform, acquired through its purchase of Dotmatics, to enhance scientific workflows and improve data sharing between research and production. 试点项目旨在加速从实验室研究向经批准的疗法过渡,目标是使病人更快地获得新的治疗。 Pilot projects aim to speed up the transition from lab research to approved therapies, with the goal of bringing new treatments to patients faster. 该倡议反映了技术和生命科学合作通过AI和数字工具推动创新的广泛趋势。 The initiative reflects a broader trend of tech and life sciences collaboration to drive innovation through AI and digital tools.